Cronos Group Inc. (CRON)

↓ Download CSV

CIK 0001656472 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Dec 31

In fiscal 2025, Cronos Group Inc. reported revenue of $146.59M, up 24.6% from the prior year. The company ran a net loss, with a net margin of -6.4% and a gross margin of 42.8%. It held $1.20B in total assets against $54.18M in total liabilities.

Key ratios (FY2025)

42.8%
Gross margin
-11.9%
Operating margin
-6.4%
Net margin
-0.8%
Return on equity
+24.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$146.59M$117.61M$87.24M$86.75M$64.56M$46.72M$23.75M$12.12M$3.15M
Gross Profit$62.76M$25.20M$11.91M$15.44M-$17.59M-$25.83M-$17.60M$6.21M$1.57M
Operating Income-$17.39M-$76.53M-$84.80M-$111.43M-$291.97M-$219.39M-$153.32M-$20.45M-$6.12M
Net Income-$9.45M$41.08M-$73.96M-$168.73M-$396.11M-$73.14M$1.17B-$21.64M-$1.48M
EPS (Diluted)$-0.02$0.11$-0.19$-0.45$-1.07$-0.21$3.33$-0.12$-0.01
Total Assets$1.20B$1.17B$1.14B$1.21B$1.40B$1.93B$2.09B$183.47M
Total Liabilities$54.18M$55.33M$44.14M$72.05M$63.46M$217.51M$341.41M$34.92M
Shareholders' Equity$1.14B$1.11B$1.10B$1.14B$1.33B$1.71B$1.75B$148.55M$63.73M$22.30M
Cash & Equivalents$791.79M$858.80M$669.29M$764.64M$886.97M$1.08B$1.20B$23.93M
Operating Cash Flow$25.87M$18.84M-$42.84M-$88.95M-$153.62M-$144.87M-$131.19M-$7.52M-$4.28M
Capital Expenditures$25.72M$12.41M$2.50M$3.45M$11.14M$31.41M$38.66M$88.31M$32.93M
Shares Outstanding383.47M385.56M380.96M376.96M370.39M351.58M342.81M172.27M176.79M